TGFB1 and Alzheimer disease: Significantly, TGFβ1 signalling counteracts the inhibitory effect of Aβ on NGF signalling (summarized in Figure 6), possibly supplementing the attenuated activity of NGF in Alzheimer's disease and representing a potential target for the development of anti-amyloid therapies.